MODULATION OF NAD+ METABOLIC PATHWAYS FOR TREATMENT OF DISEASE
- 专利权人:
- 发明人:
- Jay F. Rappaport,Xuebin Qin,Stephani Velasquez
- 申请号:
- US15780664
- 公开号:
- US20180353526A1
- 申请日:
- 2016.12.02
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention encompasses compositions and methods for regulating the kynurenine to tryptophan ratio, NAD+ level and CD16 expression for the treatment diseases.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- TARGETING K-RAS-MEDIATED SIGNALING PATHWAYS AND MALIGNANCY BY PROSTRATIN
- TARGETING K-RAS-MEDIATED SIGNALING PATHWAYS AND MALIGNANCY BY ANTI-hLIF ANTIBODIES
- TARGETING K-RAS-MEDIATED SIGNALING PATHWAYS AND MALIGNANCY BY PROSTRATIN
- TARGETING K-RAS-MEDIATED SIGNALING PATHWAYS AND MALIGNANCY BY ANTI-hLIF ANTIBODIES
- Targeting K-Ras-mediated signaling pathways and malignancy by prostratin